EUVIMEDEUVIMED entdecken
Crossref

Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience

Ondrej Fiala, Petr Hosek, Hana Korunkova, Milan Hora, Jiri Kolar, Jindra Windrichova, Ondrej Sorejs, Ondrej Topolcan, Ivan Travnicek, Hana Sedlackova, Jindrich Finek

Anticancer Research · 2023

DOI: 10.21873/anticanres.16183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Ondrej Fiala und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic; fial…. Hauptthemen laut MEDLINE: Abiraterone Acetate, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abiraterone AcetateProstatic Neoplasms, Castration-ResistantMaleHumansPrednisoneRetrospective StudiesNitrilesAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeBenzamidesPhenylthiohydantoin

Stichwörter der Autor:innen

Enzalutamideabiraterone acetatecastration-resistant prostate cancermetastaticreal-life practice

Substanzen

Abiraterone AcetatePrednisoneNitrilesenzalutamideBenzamidesPhenylthiohydantoin

Autor:innen und Institutionen

  • Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic; fialao@fnplzen.cz.
  • Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
  • Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
  • Department of Urology, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
  • Department of Immunochemistry Diagnostics, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.

Zitieren

APA

Fiala, O., Hosek, P., Korunkova, H., Hora, M., Kolar, J., Windrichova, J., Sorejs, O., Topolcan, O., Travnicek, I., Sedlackova, H., & Finek, J. (2023). Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience. Anticancer Research. https://doi.org/10.21873/anticanres.16183

Vancouver

Fiala O, Hosek P, Korunkova H, Hora M, Kolar J, Windrichova J, et al. Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience. Anticancer Research. 2023. doi:10.21873/anticanres.16183

BibTeX
@article{Fiala2023,
  author = {Fiala, Ondrej and Hosek, Petr and Korunkova, Hana and Hora, Milan and Kolar, Jiri and Windrichova, Jindra and Sorejs, Ondrej and Topolcan, Ondrej and Travnicek, Ivan and Sedlackova, Hana and Finek, Jindrich},
  title = {Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience},
  journal = {Anticancer Research},
  year = {2023},
  doi = {10.21873/anticanres.16183}
}
Kostenlos starten →